Showing results (11-20 of 499) with videos related to
Sort By:
Pageof 50
Virologica Sinica|February 16, 2020
The First Disease X is Caused by a Highly Transmissible Acute Respiratory Syndrome CoronavirusShibo Jiang, Zheng-Li ShiExpert Opinion on Therapeutic Patents|November 28, 2014
Peptide fusion inhibitors targeting the HIV-1 gp41: a patent review (2009 - 2014)Dongmei Zhang, Wen Li, Shibo JiangTrends in Immunology|April 7, 2020
Neutralizing Antibodies against SARS-CoV-2 and Other Human CoronavirusesShibo Jiang, Christopher Hillyer, Lanying DuTrends in Immunology|February 7, 2022
Developing pan-β-coronavirus vaccines against emerging SARS-CoV-2 variants of concernShan Su, Weihua Li, Shibo JiangNature Reviews. Microbiology|October 17, 2020
Learning from the past: development of safe and effective COVID-19 vaccinesShan Su, Lanying Du, Shibo JiangExpert Review of Vaccines|July 31, 2018
Prospects for a MERS-CoV spike vaccineYusen Zhou, Shibo Jiang, Lanying DuMicrobes and Infection|January 19, 2010
Research and development of universal influenza vaccinesLanying Du, Yusen Zhou, Shibo JiangBiochemical and Biophysical Research Communications|April 18, 2006
A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activityYuxian He, Jingjing Li, Shibo JiangJournal of the Formosan Medical Association = Taiwan Yi Zhi|March 9, 2010
HIV-1 gp41 fusion intermediate: a target for HIV therapeuticsChungen Pan, Shuwen Liu, Shibo JiangStem Cell Reports|March 10, 2021
Broad-Spectrum Anti-coronavirus Vaccines and Therapeutics to Combat the Current COVID-19 Pandemic and Future Coronavirus Disease OutbreaksMiao Cao, Xiaojie Su, Shibo JiangPageof 50